Zilovertamab vedotin
Synonyms: VLS-101, MK-2140
Zilovertamab vedotin (VLS-101, MK-2140) is an antibody-drug conjugate (ADC) composed of a humanised monoclonal antibody targeting ROR1 and the anti-mitotic cytotoxic agent monomethyl auristatin E (MMAE). It has potential for the treatment of lymphoid malignancies.
CAS No. 2376463-48-6
Click to purchase products related to
Quality Control
Specificity
2. "✔" indicates inhibitory effect, but without specific value.
Mechanism of Action
| Description |
Zilovertamab vedotin (VLS-101, MK-2140) is an antibody-drug conjugate (ADC) composed of a humanised monoclonal antibody targeting ROR1 and the anti-mitotic cytotoxic agent monomethyl auristatin E (MMAE). It has potential for the treatment of lymphoid malignancies.
|
References |
|---|
Product Details
| CAS No. | 2376463-48-6 |
|---|---|
| ADC antibody | Zilovertamab |
| ADC cytotoxin | MMAE |
| Formulation | 1xPBS |
| Storage | Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
Comparison of Clones for
*Literature analysis of various clone (for this target) products available on the market shows that Sellecks selected clones are more frequently applied. (data until September 2024)
Tech Support
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.